Profile of Intravenous Admixture Compatibility in The Intensive Care Unit (ICU) Patients
Journal Title: Indonesian Journal of Clinical Pharmacy - Year 2016, Vol 5, Issue 2
Abstract
Compatibility is one of the important factors determining the quality of intravenous (IV) admixtures which may directly impact to the outcome of treatment to the Intensive Care Unit (ICU) patients. The objective of this study was to identify the profile of compatibility and incompatibility among IV admixtures given to the ICU patients. This observational research was conducted prospectively to the patients admitted in the ICU at a private hospital in Surabaya from October–December 2014. In this research, compatibility data of IV drug and its solution was compared with drug brochure and Handbook on Injectable Drugs 17th ed (2013) as references to analyze the compatibility of IV admixtures. The admixture between IV drug and its solvent was classified as compatible, incompatible, no information (NI), not applicable (NA), and not clear (NC), using a specific criteria. There were 1.186 IV drug-solvent admixtures observed in 39 ICU patients. There were no IV drug-solvent admixtures classified as incompatible in both adult and child patients. Most of IV drugs were admixed with compatible solvents (adults: 72.31%; children: 69.84%). However, according to two of IV drugs compatibility references used in this research, there were some IV drug-solvent admixtures with unknown information about its compatibility that were classified as NI (adults: 19.68%; children: 30.16%). There were a few of IV drug-solvent admixtures classified as NA and NC, of 7.48% and 0.53%, respectively. The lack of information related to compatibility and stability of the IV admixtures emphasize the importance to continually monitor patients’ condition and drug concentration.
Authors and Affiliations
Sharly Dwijayanti, Sylvi Irawati, Eko Setiawan
Keywords
Related Articles
- EP ID EP365286
- DOI 10.15416/ijcp.2016.5.2.84
- Views 100
- Downloads 0
An Urinary Excretion Profile of 500 mg Ascorbic Acid in Healthy Adults
High doses of ascorbic acid have been commercially available as adjuvant. However, the pharmacological importance of this supplement is yet questionable. The aim of this study is to investigate the 24 hours excretion pro...
The Relationship of Lowering the Values of Bone Mineral Density in Methylprednisolone Medication Adherence on Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
Methylprednisolone is a glucocorticoid which has a side effect of decreasing bone mineral density (DMT). The degree of compliance relates to the occurrence of effects. The objective of this study was to investigate the a...
Impact of Pharmaceutical Home Care on Compliances and Clinical Outcomes of Hypertensive Patients
In the Indonesian health universal coverage system the hypertensive patients that grouped into the refer back patient treatment category, is one target of pharmaceutical home care. The aim of this study was to carried ou...
The Correlation of Age Factor, Administration, and Metformin Dose Against Risk of Side Effect on Type 2 Diabetes Mellitus
Metformin is an antidiabetic oral medicine commonly recommended as first line treatment on type 2 diabetes mellitus. Metformin can caused drug related problems (DRPs) such as gastrointestinal disorders, e.g. diarrhea, na...
Negative Expression of Melanoma Cell Adhesion Molecule (MCAM) Correlated with Axillary Lymph Node Metastasis in Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is breast cancers that demonstrate the absence of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2. TNBC has an aggressive behaviour, high freque...